Nathan Fischel
@Dafna Capital Management Llc
Latest period2024 - Q3ReportedManaged Assets$423.312MTotal holdings84
Assets growth rate1.14%Assets growth rate (2-Q avg)-1.79%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Dafna Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 84 positions.
Assets under management
The assets under management (AUM) of Dafna Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 423.312M in assets, with a quarterly growth rate of 1.14% and a 2-quarter average growth rate of -1.79%. The portfolio is managed by Nathan Fischel, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
LRMRLarimar Therapeutics Inc
| 0.77% | $3.237M 494,274 shares@ $6.56 avg price | Decreased -22.76% |
CATXPerspective Therapeutics Inc
| 0.73% | $3.075M 230,322 shares@ $13.36 avg price | Decreased -0.56% |
TSVT2seventy Bio Inc
| 0.71% | $2.974M 630,029 shares@ $4.73 avg price | Decreased -40.03% |
SLRNAcelyrin Inc
| 0.71% | $2.972M 602,894 shares@ $4.93 avg price | Decreased -13.07% |
ATXSAstria Therapeutics Inc
| 0.67% | $2.798M 254,165 shares@ $11.02 avg price | Decreased -7.29% |
BWAYBrainsway Ltd
| 0.55% | $2.322M 251,346 shares@ $9.24 avg price | Decreased -15.55% |
SPRYArs Pharmaceuticals Inc
| 0.51% | $2.15M 148,294 shares@ $14.5 avg price | Decreased -38% |
CNTACentessa Pharmaceuticals Plc
| 0.46% | $1.924M 120,351 shares@ $15.99 avg price | Decreased -2.05% |
MDWDMediwound Ltd
| 0.28% | $1.164M 64,479 shares@ $18.07 avg price | Decreased -48.2% |
CGENCompugen Ltd
| 0.2% | $809,436 447,202 shares@ $1.82 avg price | Decreased -3.24% |